1,046
Views
27
CrossRef citations to date
0
Altmetric
Research Paper

LncRNA FTX inhibition restrains osteosarcoma proliferation and migration via modulating miR-320a/TXNRD1

, , , , , & show all
Pages 379-387 | Received 05 Aug 2019, Accepted 01 Dec 2019, Published online: 10 Jan 2020

References

  • Lugowska I, Pienkowski A, Szumera-Cieckiewicz A, Kosela-Paterczyk H, Teterycz P, Glogowski M, Kozak K, Klimczak A, Falkowski S, Rutkowski P, et al. [The long-term treatment outcomes of adult osteosarcoma]. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego. 2017;42:158–164.
  • Ogura K, Fujiwara T, Yasunaga H, Matsui H, Jeon DG, Cho WH, Hiraga H, Ishii T, Yonemoto T, Kamoda H, et al. Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi-institutional study. Cancer. 2015;121:3844–3852. doi:10.1002/cncr.29575.
  • Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9:703–719. doi:10.4161/rna.20481.
  • Chen W, Peng R, Sun Y, Liu H, Zhang L, Peng H. The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy via the miR-449a/b/Trim11/Mek signaling pathway. Faseb J. 2019;33:11492–11506. doi:10.1096/fj201900522R.
  • Li X, Deng S, Pang X, Song Y, Luo S, Jin L, and Pan, Yet al. LncRNA NEAT1 Silenced miR-133b promotes migration and invasion of breast cancer cells. Int J Mol Sci. 2019;20:pii: E3616. doi:10.3390/ijms20153616.
  • Zhang X, Liu Z, Shu Q, Yuan S, Xing Z, Song J. LncRNA SNHG6 functions as a ceRNA to regulate neuronal cell apoptosis by modulating miR-181c-5p/BIM signalling in ischaemic stroke. J Cell Mol Med. 2019;23:6120–6130. doi: 10.1111/jcmm.14480.
  • Jiang D, Zhang Y, Yang L, Lu W, Mai L, Guo H and Liu, X. Long noncoding RNA HCG22 suppresses proliferation and metastasis of bladder cancer cells by regulation of PTBP1. J Cell Physiol. 2019;235:1711–1722. doi:10.1002/jcp.29090.
  • Jiang L, Wang R, Fang L, Ge X, Chen L, Zhou M, Zhou Y, Xiong W, Hu Y, Tang X, et al. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis. Theranostics. 2019;9:2460–2474. doi:10.7150/thno.31097.
  • Cai Y, Sheng Z, Chen Y, Wang J. LncRNA HMMR-AS1 promotes proliferation and metastasis of lung adenocarcinoma by regulating MiR-138/sirt6 axis. Aging. 2019;11:3041–3054. doi:10.18632/aging.v11i10.
  • Zhang JJ, Fan LP. Long non-coding RNA CRNDE enhances cervical cancer progression by suppressing PUMA expression. Biomed Pharmacother. 2019;117:108726. doi:10.1016/j.biopha.2019.108726.
  • Li X, Zhao Q, Qi J, Wang W, Zhang D, Li Z and Qin, C. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARgamma pathway in hepatocellular carcinoma. Int J Oncol. 2018;53:551–566.
  • He X, Sun F, Guo F, Wang K, Gao Y, Feng Y and Li, Y. Knockdown of Long Noncoding RNA FTX Inhibits Proliferation, Migration, and Invasion in Renal Cell Carcinoma Cells. Oncol Res. 2017;25:157–166.
  • Guo XB, Hua Z, Li C, Peng LP, Wang JS, Wang B, Zhi QM, et al. Biological significance of long non-coding RNA FTX expression in human colorectal cancer. Int J Clin Exp Med. 2015;8:15591–15600.
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36(Suppl 1):S67–74. doi:10.2337/dc13-S067
  • Gong N, Gong M. MiRNA-221 from tissue may predict the prognosis of patients with osteosarcoma. Medicine. 2018;97:e11100. doi:10.1097/MD.0000000000011100.
  • Wang SN, Luo S, Liu C, Piao Z, Gou W, Wang Y, Guan W, Li Q, Zou H, Yang ZZ, et al. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting alphaB-crystallin. J Am Soc Gene Ther. 2017;25:2140–2149. doi:10.1016/j.ymthe.2017.05.018.
  • Li Y, Liu H, Shao J, Xing G. miR-320a serves as a negative regulator in the progression of gastric cancer by targeting RAB14. Mol Med Rep. 2017;16:2652–2658.
  • Fu B, Meng W, Zeng X, Zhao H, Liu W, Zhang T. TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma. Biomed Res Int. 2017;2017:4698167. doi:10.1155/2017/4698167.
  • Hao C, Xu X, Ma J, Xia J, Dai B, Liu L, Ma Y. MicroRNA-124 regulates the radiosensitivity of non-small cell lung cancer cells by targeting TXNRD1. Oncol Lett. 2017;13:2071–2078.
  • Li X, Li B, Ran P, Wang L. Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma. Oncol Lett. 2018;16:5697–5708. doi:10.3892/ol.2018.9336.
  • Guo W, Jiang H, Li H, Li F, Yu Q, Liu Y, Jiang W, Zhang M. LncRNA-SRA1 suppresses osteosarcoma cell proliferation while promoting cell apoptosis. Technol Cancer Res Treat. 2019;18:1533033819841438.
  • Wu L, Liu D, Yang Y. Enhanced expression of circular RNA circ-DCAF6 predicts adverse prognosis and promotes cell progression via sponging miR-1231 and miR-1256 in gastric cancer. Exp Mol Pathol. 2019;110:104273. DOI: 10.1016/j.yexmp.2019.104273.
  • Liu W. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21. Cancer Biother Radiopharm. 2019;34:258–263. doi:10.1089/cbr.2018.2684.
  • Zhao W, Sun Q, Yu Z, Mao S, Jin Y, Li J, Jiang Z, Zhang Y, Chen M, Chen P, et al. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway. Gene. 2018;670:31–37. doi:10.1016/j.gene.2018.05.100.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.